Clinical Trial Update: Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients

View source ↗

Summary

The completed clinical trial evaluates whether the neutrophil-to-lymphocyte ratio (NLR) has prognostic value for outcomes in rectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: General Hospital of Ningxia Medical University | Conditions: Rectal Cancer, Prognosis | Status: COMPLETED